Loading insider details...
Latest Form 4 (Aug 5, 2026): Sale of 9,700 FTRE shares, $174.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Fortrea Holdings Inc. (FTRE) | Sale | 9,700 | $174.7K |
| Jun 15, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 15,294 | n/a |
| Jun 12, 2026 | Fortrea Holdings Inc. (FTRE) | Exercise/Conversion | 38,817 | n/a |
| Nov 17, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale | 9,600 | $68.5K |
| Jun 16, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 12,500 | n/a |
| Jun 12, 2025 | Fortrea Holdings Inc. (FTRE) | Grant/Award | 38,817 | n/a |
| May 16, 2025 | Fortrea Holdings Inc. (FTRE) | Exercise/Conversion | 7,282 | n/a |
| Jun 17, 2024 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Sale | 4,689 | $28.1K |
| Jun 14, 2024 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 6,820 | n/a |
| May 16, 2024 | Fortrea Holdings Inc. (FTRE) | Grant/Award | 7,282 | n/a |